Aequitron Medical acquires central nervous systems (CNS) sleep diagnostic range:
This article was originally published in Clinica
Executive Summary
Electronic respiratory product manufacturer Aequitron Medical is to acquire CNS' sleep diagnostic business which has annual revenues of $7 million. The combined $6 million cash and debt transaction gives Aequitron rights to all CNS' sleep disorder diagnostic products as well as a product in development. It also gains distribution rights to CNS' Breathe Right nasal strips to professional healthcare markets. Production and staffing for the CNS products will move to Aequitron Medical's headquarters in Plymouth, Minnesota. CNS chairman and CEO Daniel Cohen says the company intends to concentrate on developing its core business - the Breathe Right product line.